BONO, GIORGIO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 13.648
EU - Europa 9.550
AS - Asia 4.949
SA - Sud America 499
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 77
OC - Oceania 4
Totale 28.835
Nazione #
US - Stati Uniti d'America 13.471
IT - Italia 5.305
UA - Ucraina 1.490
SG - Singapore 1.449
CN - Cina 1.168
VN - Vietnam 775
TR - Turchia 759
SE - Svezia 548
HK - Hong Kong 542
FI - Finlandia 450
BR - Brasile 412
DE - Germania 400
IE - Irlanda 353
FR - Francia 312
GB - Regno Unito 268
RU - Federazione Russa 212
CA - Canada 89
IN - India 72
NL - Olanda 72
MX - Messico 64
BD - Bangladesh 62
AR - Argentina 31
JP - Giappone 26
ES - Italia 24
AT - Austria 21
EU - Europa 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
BE - Belgio 18
EC - Ecuador 14
MA - Marocco 14
CO - Colombia 13
NG - Nigeria 13
CL - Cile 12
PL - Polonia 12
SA - Arabia Saudita 12
IQ - Iraq 11
PK - Pakistan 10
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
VE - Venezuela 8
EG - Egitto 7
KE - Kenya 7
MD - Moldavia 7
PH - Filippine 7
CH - Svizzera 6
NP - Nepal 6
AZ - Azerbaigian 5
DZ - Algeria 5
PY - Paraguay 5
RO - Romania 5
AU - Australia 4
KR - Corea 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
GR - Grecia 3
HN - Honduras 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
TN - Tunisia 3
UZ - Uzbekistan 3
AO - Angola 2
BG - Bulgaria 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
TG - Togo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
Totale 28.744
Città #
Milan 3.213
Fairfield 1.259
Jacksonville 1.160
San Jose 1.086
Woodbridge 986
Ashburn 973
Singapore 757
Chandler 745
Houston 698
Ann Arbor 561
Hong Kong 536
Wilmington 532
Seattle 509
Cambridge 399
Princeton 395
Dallas 389
Izmir 372
Dublin 350
Beijing 321
Council Bluffs 319
Dearborn 289
Rome 269
Nyköping 238
Dong Ket 236
The Dalles 227
Boardman 212
Bryn Mawr 199
Lauterbourg 162
Como 141
San Mateo 141
Chicago 131
Ho Chi Minh City 115
San Diego 86
Ogden 85
Santa Clara 84
Helsinki 74
Hanoi 73
Los Angeles 68
New York 64
Washington 58
Toronto 57
Orem 49
Hefei 48
Frankfurt am Main 47
Turin 47
London 46
Guangzhou 42
Mexico City 41
Trieste 40
Verona 37
Norwalk 35
São Paulo 34
Shanghai 33
Kocaeli 31
Saint Petersburg 31
Zhengzhou 31
Kunming 30
Munich 27
Nanjing 27
Nuremberg 26
Tokyo 26
Chennai 25
San Francisco 22
Düsseldorf 20
Naples 20
Denver 19
Turku 18
Bologna 17
Buffalo 17
Manchester 17
Tianjin 17
Jinan 16
Stockholm 16
Wuhan 15
Brno 14
Brussels 14
Hangzhou 14
Johannesburg 14
Montreal 14
Nanchang 14
Phoenix 14
Shenzhen 14
Varese 14
Abuja 13
Bari 13
Padova 13
Fuzhou 12
Haiphong 12
Hải Dương 12
Mountain View 12
Missaglia 11
Mumbai 11
Rio de Janeiro 11
Shenyang 11
Amsterdam 10
Auburn Hills 10
Brescia 10
Caserta 10
Columbus 10
Vienna 10
Totale 19.853
Nome #
Standardizzazione di due nuovi test di memoria: apprendimento di liste di parole correlate e non correlate semanticamente. 1.495
Memory impairment in Cushing's disease 355
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease 243
Temporal Trends in Ischemic and Hemorrhagic Strokes in Northern Italy: Results from the Cardiovascular Monitoring Unit in Northern Italy Population. Based Register, 1998-2004. 236
Adherence to anti-Parkinson drug therapy in the “REASON” sample of Italian patients with Parkinson’s disease: the linguistic validation of the Italian version of the “Morisky Medical Adherence scale-8 items” 234
PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology 234
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 232
A case-control study of hormonal exposures as etiologic factors for ALS in women 224
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients 218
Time to hospital admission and start of treatment in patients with ischemic stroke in northern Italy and predictors of delay 217
Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry 210
Anticoagulation After Stroke in Patients With Atrial Fibrillation: To Bridge or Not With Low-Molecular-Weight Heparin? 210
Persistence of poliovirus genome in polio survivors diagnosed with post-polio syndrome 209
Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease 208
Impact of gender differences on the outcome of Alzheimer's disease 207
Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study 203
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis 201
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 200
A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review 199
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 199
Screening for Fabry disease in patients with ischaemic stroke at young age: the Italian Project on Stroke in Young Adults 199
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus 198
Long-term Follow-up of Young Adults With Stroke 196
Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study 196
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 195
Postinfectious neurologic syndromes: A prospective cohort study 194
Predictors of long-term recurrent vascular events after ischemic stroke at young age: The Italian project on stroke in young adults 192
MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death 191
. Post-surgical reversible cerebral vasoconstriction syndrome in a pediatric patient with Chiari I malformation. 191
Chronic intrathecal baclofen infusion for spasticity: Relationship between pump and host 190
Results of Membrane-activated Chelator Stroke Intervention Randomized Trial of DP-b99 in Acute Ischemic Stroke 190
Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients 189
Reducing time delays in the management of ischemic stroke patients in Northern Italy 188
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 186
Headache attributed to head or neck trauma 181
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 180
Primary leptomeningeal CNS lymphoma presenting as bilateral facial nerve palsy 179
Long-term survival in amyotrophic lateral sclerosis: A population-based study 178
Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users 177
Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers 174
Adverse reaction to COMT inhibitors in Parkinson's disease patients: possible association with the UGTIA9 gene haplotype 173
The role of morpho-volumetric and memory correlations in the diagnosis of early Alzheimer dementia 171
Peripheral nerve conduction study in children and adolescents at the clinical onset of type 1 diabetes and at five of more years postdiagnosis 171
Persistent trigeminal artery causing double neurovascular conflict 170
Endovascular Treatment for Acute Ischemic Stroke 170
Unbalanced metalloproteinase-9 and tissue inhibitors of metalloproteinases ratios predict hemorrhagic transformation of lesion in ischemic stroke patients treated with thrombolysis: Results from the MAGIC study 170
Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol-o-methyltransferase inhibitors in Parkinson’s disease patients 167
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 167
Meeting patient expectations in migraine treatment: what are the key endpoints? 166
Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy 166
Expression of apoptosis-related proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease. 164
Interaction between proatherosclerotic factors and right-to-left shunt on the risk of cryptogenic stroke: the Italian Project on Stroke in Young Adults. 163
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 163
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 162
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 162
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson's disease 162
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: the ICARO study 161
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes 161
Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment 161
Memory functioning at menopause: impact of age in ovariectomized women 159
The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions. 159
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 159
Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach 159
Relapsing-remitting painful ophthalmoplegia due to orbital myositis 157
Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs 157
Hepatotoxicity after high-dose methylprednisolone for demyelinating disease 156
Three-years neuropsychological follow-up in a selected group of HIV-infected homsexual-bisexual men 156
Prevalenza della sindrome metabolica e declino cognitivo nei soggetti anziani 155
Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood 154
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease 154
Lessons from placebo effects in migraine treatment 152
A peculiar headache as first manifestation of non-metastatic lung cancer 152
Stroke management in northern Lombardy: organization of an emergency-urgency network and development of a connection between prehospital and in-hospital settings. 152
Cognitive abnormalities and disease progression in a selected population of asymptomatic HIV-positive subjects. 152
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 152
Adrenergic and dopaminergic pathways in circulating lymphocytes as early markers of clinically isolated syndromes progressing to multiple sclerosis 151
Memory functioning at menopause: impact to age in ovariectomized women. 151
Amisulpride can control bevioural symptoms in patients with moderate-severe Alzheimer's disease 150
Pathophysiology of the post-polio syndrome and persistence of poliovirus genomes in polio survivors 150
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial 150
Concepts leading to the definition of the term cervicogenic headache: a historical overview 148
3D kinematic analysis of neck movement in control subjects: reliability of the procedure 147
Effecys of Natalizumab on CD4+CD25+FoxP3+ regulatory T lymphocytes in multiple sclerosis patients 147
Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion. 146
Cervicogenic headache: evaluation of the original diagnostic criteria 146
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 146
Headache attributed to infection: observations on the IHS classification (ICHD-II) 145
Driving habits in patients with dementia: A report from Alzheimer’s disease assessment units in northern Italy 145
Stroke emergency management in a large geographic area of Northern Italy 143
Diagnosing cervicogenic headache 142
Italian guidelines for primary headaches: 2012 revised version. 140
A patient preference study of frovatriptan versus rizatriptan for the acute treatment of migraine 139
TNF-alpha 308 G/A and 238 G/A promoter polymorphisms and sporadic Parkinson's disease in an Italian cohort 139
De-novo headache with transient vertebro-basilar symptoms: role of the embryonic hypoglossal artery 138
Persisting poliovirus infection in patients with the Post-Polio Syndrome (PPS) 138
Age and gender differences in the management of stroke in the emergency setting: results from a study in a macro-area of northern Lombardy 137
How parkinsonism influences life the patients' point of view 137
Cerebral sinus thrombosis in ulcerative colitis. 137
Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes 137
Lesson from placebo effect in migraine tretment 136
Totale 18.718
Categoria #
all - tutte 109.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.631 0 257 155 145 52 49 73 116 95 247 165 277
2022/20232.158 239 104 139 226 151 496 17 279 307 60 71 69
2023/20244.866 720 734 804 974 895 344 74 77 125 45 25 49
2024/20252.453 33 38 495 49 49 159 99 171 251 181 186 742
2025/20265.953 383 399 299 599 550 357 1.270 382 722 459 331 202
2026/2027648 326 322 0 0 0 0 0 0 0 0 0 0
Totale 28.835